Drug intelligence / Profile preview

Fortaline Plus

Development stage
Unknown
Lead developer
Dafra Pharma
Modality
Small Molecules
Administration
Oral
01

Overview

Fortaline Plus is a nutritional supplement developed and marketed by Dafra Pharma, primarily targeting the Sub-Saharan African market. It is formulated as a combination of fish oil and vitamin E to support general health, cognitive development, and cardiovascular function. Each capsule typically contains 500 mg of fish oil, providing essential omega-3 fatty acids, specifically eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), alongside 10 mg of vitamin E. The product utilizes EnteriCare™ anti-reflux technology to minimize the fishy aftertaste often associated with fish oil supplements. It is recommended for a wide demographic, including children, adults, and pregnant or breastfeeding women, to support overall physiological development and well-being.

Brand names
Fortaline Plus
02

Targets

FFAR4 (Free fatty acid receptor 4)PPARA (Peroxisome proliferator-activated receptor alpha)PPARG (Peroxisome proliferator-activated receptor gamma)

Beyond the preview

Go deeper on Fortaline Plus.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Fortaline Plus.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call